{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:36:29Z","timestamp":1791671789779,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jns.2020.117167","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T10:47:40Z","timestamp":1601722060000},"page":"117167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical characteristics and diagnostic clues to Neurometabolic causes of dystonia"],"prefix":"10.1016","volume":"419","author":[{"given":"Chun Seng","family":"Phua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.117167_bb0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117167_bb0010","first-page":"1","article-title":"Classification of dystonia","volume":"78","author":"Fahn","year":"1998","journal-title":"Adv. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jnnp.2003.017632","article-title":"Characteristics of dystonic movements in primary and symptomatic dystonias","volume":"75","author":"Svetel","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14802\/jmd.09016","article-title":"Secondary dystonia-clinical clues and syndromic associations","volume":"2","author":"Schneider","year":"2009","journal-title":"J. Mov. Disord."},{"issue":"8\u20139","key":"10.1016\/j.jns.2020.117167_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neurol.2016.07.011","article-title":"Neurometabolic disorders are treatable causes of dystonia","volume":"172","author":"Kuiper","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jns.2020.117167_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25879","article-title":"Loss-of-function variants in HOPS complex genes VPS16 and VPS41 cause early-onset dystonia associated with lysosomal abnormalities","author":"Steel","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0035","series-title":"GLB1-Related Disorders","author":"Regier","year":"1993"},{"key":"10.1016\/j.jns.2020.117167_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2019.11.004","article-title":"Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes","volume":"69","author":"Kumar","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00293589","article-title":"GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types","volume":"43","author":"Suzuki","year":"1978","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jns.2020.117167_bb0050","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/mds.20193","article-title":"Clinical features of adult GM1 gangliosidosis: report of three Indian patients and review of 40 cases","volume":"19","author":"Muthane","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117167_bb0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1590\/S0004-282X2011000300028","article-title":"Facial grimacing as a clue for the diagnosis of GM1 type 3 gangliosidosis","volume":"69","author":"ROH","year":"2011","journal-title":"Assoc. Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mdc3.12197","article-title":"Gangliosidosis with characteristic \u201cWish Bone Sign\u201d on brain MRI. Another type of neurodegeneration with brain iron accumulation?","volume":"2","author":"Hajirnis","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2020.117167_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816593","article-title":"Recent advances in the diagnosis and treatment of Niemann-Pick disease type C in children: a guide to early diagnosis for the general pediatrician","volume":"2015","author":"Alobaidy","year":"2015","journal-title":"Int. J. Pediatr."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00415-013-7159-9","article-title":"Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-pick C disease","volume":"261","author":"Anheim","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","article-title":"Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management","volume":"9","author":"Nie","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.jns.2020.117167_bb0090","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2169\/internalmedicine.0120-17","article-title":"Late-onset cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene","volume":"57","author":"Sasamura","year":"2018","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2020.117167_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.57.4.520","article-title":"Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis","volume":"57","author":"Verrips","year":"2000","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-013-9674-3","article-title":"A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis","volume":"37","author":"Mignarri","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0110","first-page":"402","article-title":"The first cerebrotendinous xanthomatosis family from Argentina: a new mutation in CYP27A1 gene","volume":"70","author":"Szlago","year":"2008","journal-title":"Neurol. Int."},{"issue":"9","key":"10.1016\/j.jns.2020.117167_bb0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/mds.22585","article-title":"Oromandibular dystonia as a complication of cerebrotendinous xanthomatosis","volume":"24","author":"Alcalay","year":"2009","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0120","first-page":"556","article-title":"Cerebrotendinous xanthomatosis with oromandibular dyskinesia","volume":"51","author":"Bordia","year":"2003","journal-title":"Neurol. India"},{"issue":"14","key":"10.1016\/j.jns.2020.117167_bb0125","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/mds.25206","article-title":"Myoclonus and dystonia in cerebrotendinous xanthomatosis","volume":"27","author":"Lagarde","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/brain\/124.1.121","article-title":"Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis","volume":"124","author":"De Stefano","year":"2001","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.ejhg.5200272","article-title":"Spectrum of mutations in fucosidosis","volume":"7","author":"Willems","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ajmg.1320380125","article-title":"Fucosidosis revisited: a review of 77 patients","volume":"38","author":"Willems","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.jns.2020.117167_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0039-1684052","article-title":"A novel homozygous mutation in the FUCA1 gene highlighting fucosidosis as a cause of dystonia: case report and literature review","volume":"50","author":"Wali","year":"2019","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0160","first-page":"e33","article-title":"Teaching neuro images: distinct neuroimaging features of fucosidosis","volume":"78","author":"Jain","year":"2012","journal-title":"Neurol. Int."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11011-017-9968-5","article-title":"Brain abnormalities in fucosidosis: transplantation or supportive therapy?","volume":"32","author":"Jiang","year":"2017","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000260","article-title":"Case of late-onset Sandhoff disease due to a novel mutation in the HEXB gene","volume":"4","author":"Sung","year":"2018","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jns.2020.117167_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymgmr.2018.07.003","article-title":"Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms","volume":"16","author":"Kumar","year":"2018","journal-title":"Mol. Genet. Metab. Reports"},{"key":"10.1016\/j.jns.2020.117167_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jocn.2011.09.009","article-title":"Late-adult onset Leigh syndrome","volume":"19","author":"McKelvie","year":"2012","journal-title":"J. Clin. Neurosci. Churchill Livingstone"},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0972-2327.175437","article-title":"Adult-onset Leigh's disease: a rare entity","volume":"19","author":"Jabeen","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JND-150121","article-title":"Adult onset Leigh syndrome in the intensive care setting: a novel presentation of a C12orf65 related mitochondrial disease","volume":"2","author":"Wesolowska","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fneur.2019.00347","article-title":"A chinese family with adult-onset leigh-like syndrome caused by the heteroplasmic m.10191T>C mutation in the mitochondrial MTND3 gene","volume":"10","author":"Li","year":"2019","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2020.117167_bb0200","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","article-title":"Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease","volume":"73","author":"Martikainen","year":"2016","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bjophthalmol-2014-305704","article-title":"Ophthalmological manifestations in patients with Leigh syndrome","volume":"99","author":"Han","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-9-52","article-title":"A multicenter study on Leigh syndrome: disease course and predictors of survival","volume":"9","author":"Sofou","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0215","first-page":"1","article-title":"Molecular basis of Leigh syndrome: a current look","volume":"15","author":"Schubert","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"8","key":"10.1016\/j.jns.2020.117167_bb0220","first-page":"1502","article-title":"Leigh syndrome: serial MR imaging and clinical follow-up","volume":"21","author":"Junko Arii","year":"2000","journal-title":"Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0225","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/197140091102400312","article-title":"Proton MR spectroscopy in patients with Leigh syndrome","volume":"24","author":"Jurkiewicz","year":"2011","journal-title":"Neuroradiol. J."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-8-83","article-title":"Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases","volume":"8","author":"Alfadhel","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0235","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archneur.55.5.722","article-title":"A case of late-onset MELAS","volume":"55","author":"Kimata","year":"1998","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12883-019-1306-6","article-title":"Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report","volume":"19","author":"Sinnecker","year":"2019","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0245","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/brain\/118.3.721","article-title":"The mitochondrial DNA transfer RNALeu(UUR) A-->G(3243) mutation. A clinical and genetic study","volume":"118","author":"Hammans","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jns.2020.117167_bb0250","first-page":"591","article-title":"Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes","volume":"73","author":"Koenig","year":"2016","journal-title":"JAMA Neurol. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0255","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ana.410310408","article-title":"MELAS: clinical features, biochemistry, and molecular genetics","volume":"31","author":"Ciafaloni","year":"1992","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.59.2.160","article-title":"Leber's \u201cplus\u201d: neurological abnormalities in patients with Leber's hereditary optic neuropathy","volume":"59","author":"Nikoskelainen","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jns.2020.117167_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.11.003","article-title":"Leber's hereditary optic neuropathy with dystonia in a Japanese family","volume":"243","author":"Watanabe","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1445-5994.2012.02847.x","article-title":"POLG mutations in Australian patients with mitochondrial disease","volume":"43","author":"Woodbridge","year":"2013","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jns.2020.117167_bb0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.23960","article-title":"Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations","volume":"27","author":"Hinnell","year":"2012","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mdc3.12397","article-title":"Dystonia in a patient with autosomal-dominant progressive external Ophthalmoplegia type 1 caused by mutation in the POLG gene","volume":"4","author":"Rossi","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.20550","article-title":"Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: Dihydrolipoamide acetyltransferase (E2) deficiency","volume":"58","author":"Head","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0295","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejpn.2015.04.008","article-title":"Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review","volume":"19","author":"Castiglioni","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3174\/ajnr.A0770","article-title":"Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging","volume":"29","author":"Harder","year":"2008","journal-title":"Am. J. Neuroradiol."},{"issue":"12","key":"10.1016\/j.jns.2020.117167_bb0305","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/mds.21170","article-title":"Neurological manifestations in Wilson's disease: report of 119 cases","volume":"21","author":"Machado","year":"2006","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0310","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3174\/ajnr.A5936","article-title":"MR imaging of the brain in neurologic Wilson disease","volume":"40","author":"Yu","year":"2019","journal-title":"Am. J. Neuroradiol."},{"issue":"7","key":"10.1016\/j.jns.2020.117167_bb0315","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.WNL.0000085871.98174.4E","article-title":"The \u201cdouble panda sign\u201d in Wilson's disease","volume":"61","author":"Jacobs","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0320","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/mds.1118","article-title":"Dystonia in Wilson's disease","volume":"16","author":"Svetel","year":"2001","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0325","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/brain\/awr042","article-title":"Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration","volume":"134","author":"Kruer","year":"2011","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0330","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/jon.12195","article-title":"Neurodegeneration with brain iron accumulation: clinicoradiological approach to diagnosis","volume":"25","author":"Amaral","year":"2015","journal-title":"J. Neuroimaging"},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa020817","article-title":"Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome","volume":"348","author":"Hayflick","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0340","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mdc3.12393","article-title":"Neurodegeneration with Brain Iron accumulation (NBIA) syndromes presenting with late-onset Craniocervical dystonia: an illustrative case series","volume":"4","author":"Brugger","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jns.2020.117167_bb0345","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/mdc3.12035","article-title":"Characteristic \u201cforcible\u201d Geste Antagoniste in Oromandibular dystonia resulting from Pantothenate kinase-associated Neurodegeneration","volume":"1","author":"Petrovi\u0107","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"10","key":"10.1016\/j.jns.2020.117167_bb0350","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/mds.25490","article-title":"Dystonic opisthotonus: a \u201cred flag\u201d for neurodegeneration with brain iron accumulation syndromes?","volume":"28","author":"Stamelou","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117167_bb0355","series-title":"Tremor and Other Hyperkinetic Movements","article-title":"Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management","volume":"2016","author":"Kumar","year":"2016"},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ajhg.2012.01.017","article-title":"Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease","volume":"90","author":"Quadri","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.jns.2020.117167_bb0365","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.25138","article-title":"Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder","volume":"27","author":"Stamelou","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117167_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-008-0813-1","article-title":"Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia - a new metabolic disorder","author":"Tuschl","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0375","first-page":"7","article-title":"Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia","volume":"27","author":"Tuschl","year":"2016","journal-title":"Nat. Commun."},{"issue":"1 Supplement","key":"10.1016\/j.jns.2020.117167_bb0380","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/BF02138786","article-title":"Neurological manifestations of organic acid disorders","volume":"153","author":"Hoffmann","year":"1994","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jns.2020.117167_bb0385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41582-019-0161-9","article-title":"Neurological manifestations of organic acidurias","volume":"15","author":"Wajner","year":"2019","journal-title":"Nat. Rev. Neurol. Nat. Publ. Group"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0390","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1005543904484","article-title":"Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy","volume":"22","author":"Hoffmann","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0395","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mdc3.12237","article-title":"Methylmalonic Aciduria: a treatable disorder of which adult neurologists need to be aware","volume":"3","author":"Tan","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0400","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3174\/ajnr.A4087","article-title":"MRI characteristics of globus pallidus infarcts in isolated methylmalonic acidemia","volume":"36","author":"Baker","year":"2015","journal-title":"Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0405","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0887-8994(92)90085-D","article-title":"Neurologic outcome of propionic acidemia","volume":"8","author":"Surtees","year":"1992","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2020.117167_bb0410","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jnnp.51.6.859","article-title":"Dystonia in homocystinuria","volume":"51","author":"Kempster","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0415","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000325703","article-title":"Treatment of Homocystinuria-related dystonia with deep Brain stimulation: a case report","volume":"89","author":"Aydin","year":"2011","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.jns.2020.117167_bb0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpn.2011.09.005","article-title":"Glut1 deficiency: when to suspect and how to diagnose?","volume":"16","author":"Verrotti","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/mdc3.12007","article-title":"The clinical syndrome of paroxysmal exercise-induced dystonia: diagnostic outcomes and an algorithm","volume":"1","author":"Erro","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jns.2020.117167_bb0430","first-page":"1440","article-title":"Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: A systematic review","volume":"70","author":"Leen","year":"2013","journal-title":"JAMA Neurol. Am. Med. Assoc."},{"issue":"11","key":"10.1016\/j.jns.2020.117167_bb0435","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/dmcn.13167","article-title":"Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome","volume":"58","author":"Amalou","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.jns.2020.117167_bb0440","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mds.25348","article-title":"Movement disorders in adult patients with classical Galactosemia","volume":"28","author":"Rubio-Agusti","year":"2013","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0445","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10545-006-0382-0","article-title":"Classical galactosaemia revisited","volume":"29","author":"Bosch","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0450","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pediatrneurol.2005.02.015","article-title":"An updated review of the long-term neurological effects of galactosemia","volume":"33","author":"Ridel","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0455","first-page":"113","article-title":"Galactosaemia: diagnosis, management and long-term outcome","volume":"25","author":"Broomfield","year":"2015","journal-title":"Churchill Livingstone"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0460","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2004.03.017","article-title":"Misdiagnoses in children with dopa-responsive dystonia","volume":"31","author":"Jan","year":"2004","journal-title":"Pediatr. Neurol."},{"issue":"S 01","key":"10.1016\/j.jns.2020.117167_bb0465","doi-asserted-by":"crossref","DOI":"10.1055\/s-0036-1583737","article-title":"Dopamine-responsive dystonia: an important differential diagnosis to cerebral palsy","volume":"47","author":"Gabriel","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jns.2020.117167_bb0470","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/iub.1140","article-title":"The neurobiology of tetrahydrobiopterin biosynthesis: a model for regulation of GTP cyclohydrolase i gene transcription within nigrostriatal dopamine neurons","volume":"65","author":"Kapatos","year":"2013","journal-title":"IUBMB Life"},{"issue":"8","key":"10.1016\/j.jns.2020.117167_bb0475","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0480","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1373\/clinchem.2007.099986","article-title":"Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid","volume":"54","author":"Hyland","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jns.2020.117167_bb0485","series-title":"GeneReviews(R)","article-title":"GTP cyclohydrolase 1-deficient dopa-responsive dystonia","author":"Furukawa","year":"2019"},{"issue":"6","key":"10.1016\/j.jns.2020.117167_bb0490","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0495","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pediatrneurol.2006.05.006","article-title":"Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy","volume":"35","author":"Echenne","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2020.117167_bb0500","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/brain\/awh603","article-title":"Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder","volume":"128","author":"Neville","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2020.117167_bb0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0510","first-page":"64","article-title":"Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jns.2020.117167_bb0515","first-page":"1","article-title":"The genetic and clinical characteristics of aromatic L-amino acid decarboxylase deficiency in mainland China","volume":"14","author":"Wen","year":"2020","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0520","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.20055","article-title":"Levodopa-responsive aromatic L-amino acid decarboxylase deficiency","volume":"55","author":"Chang","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0525","first-page":"497","article-title":"Clinical recognition and aspects of the cerebral folate deficiency syndromes","author":"Ramaekers","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0530","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ymgme.2004.12.001","article-title":"Cerebral folate deficiency: life-changing supplementation with folinic acid","volume":"84","author":"Hansen","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0535","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.64.3.368","article-title":"Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich's ataxia","volume":"64","author":"Hammans","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0540","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mds.10026","article-title":"Myoclonic dystonia as unique presentation of isolated vitamin E deficiency in a young patient","volume":"17","author":"Angelini","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2020.117167_bb0545","article-title":"Ataxia with vitamin e deficiency may present with cervical dystonia","volume":"2016","author":"Becker","year":"2016","journal-title":"Tremor and Other Hyperkinetic Mov."},{"issue":"3","key":"10.1016\/j.jns.2020.117167_bb0550","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10072-004-0246-z","article-title":"Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families","volume":"25","author":"Mariotti","year":"2004","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117167_bb0555","first-page":"73","article-title":"Juvenile neuronal ceroid lipofuscinosis (batten disease): current insights","volume":"6","author":"Ostergaard","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2020.117167_bb0560","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S1474-4422(11)70232-0","article-title":"Primary dystonia and dystonia-plus syndromes: Clinical characteristics, diagnosis, and pathogenesis","volume":"10","author":"Phukan","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117167_bb0565","series-title":"Inborn Metabolic Diseases: Diagnosis and Treatment","first-page":"239","article-title":"Creatine deficiency syndromes","author":"Stockler-Ipsiroglu","year":"2012"},{"key":"10.1016\/j.jns.2020.117167_bb0570","series-title":"Handbook of Clinical Neurology","first-page":"1827","article-title":"Metabolic disorders of purine metabolism affecting the nervous system","author":"Jinnah","year":"2013"},{"issue":"5","key":"10.1016\/j.jns.2020.117167_bb0575","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awl056","article-title":"Delineation of the motor disorder of Lesch\u2013Nyhan disease","volume":"129","author":"Jinnah","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2020.117167_bb0580","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","article-title":"A familial disorder of uric acid metabolism and central nervous system function","volume":"36","author":"Lesch","year":"1964","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2020.117167_bb0585","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12311-018-0969-7","article-title":"High degree of genetic heterogeneity for hereditary cerebellar ataxias in Australia","volume":"18","author":"Kang","year":"2019","journal-title":"Cerebellum"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:51:35Z","timestamp":1758383495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20305037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":117,"alternative-id":["S0022510X20305037"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117167","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and diagnostic clues to Neurometabolic causes of dystonia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117167"}}